Priority Date: 30.11.11 (US 201161565400P)

PERSONALIZED PAIN MANAGEMENT AND ANESTHESIA: PREEMPTIVE RISK IDENTIFICATION AND THERAPEUTIC DECISION SUPPORT

  • Application ID: EP12854522
  • Status: EXAMINATION IN PROGRESS

Applicant

Attorneys

no operation time available
Headquarter in Bristol and 6 offices
active in Legal Services and IP Consulting
Employment test 51 - 200 employees
Company dna maiwald patentanwalts gmbh
operating since 1995
Headquarter in Munich and 4 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination C07 (ORGANIC CHEMISTRY) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination C07 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 144 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 30.11.2011 - Priority Date (US 201161565400P)
  • 06.06.2013 - Publication A1 (WO2013082308)
  • 08.10.2014 - Publication A1 (EP2785874)